Jupiter Neurosciences executives forgive $875,315 in accrued pay
Four officers and directors waived unpaid compensation in agreements signed August 26, 2026, with no shares or cash exchanged in return.
Jupiter Neurosciences, Inc. disclosed in an 8-K that on August 26, 2026, it signed separate Debt Forgiveness and Release Agreements with several of its executive officers and directors. Under these agreements, the individuals irrevocably forgave an aggregate of $875,315 of accrued and unpaid compensation previously owed by the Company.1 These sums represented unpaid salary that the company had been carrying as a liability on its books, rather than a new form of compensation.
The filing breaks down the amounts by individual: Christer Rosén, Chairman, CEO and director, forgave $356,024; Alison Silva, President and COO and director, forgave $81,431; Marshall Hayward, Ph.D., Chief Scientific Officer and director, forgave $287,075; and Alexander Rosén, Chief Administrative Officer, forgave $150,785, according to the table setting forth the amounts forgiven by each individual.1
The company said no equity, cash, or other consideration was given in exchange for the waived pay; the arrangement was structured as an outright gift from each executive to the company. Each agreement also includes a release provision, under which the executives gave up claims against the company and its affiliates tied to the forgiven compensation, with some standard carve-outs, including preserving rights under the forgiveness agreement itself.
Separately, the filing notes that as of the report date, the Company has 1,318,521 shares of Common Stock issued and outstanding.1 The full agreement terms are attached as Exhibit 10.1 to the filing, which was signed by CEO Christer Rosen on August 27, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.